NASDAQ:MNOV - MediciNova, Inc.
$9.22
 $-0.63
-6.40%
4:00PM EDT
2019-04-18
Medicinova, Inc. is a biopharmaceutical company. The Company focuses on acquiring and developing small molecule therapeutics for the treatment of diseases with unmet medical needs and a commercial focus on the United States market. Its pipeline includes MN-166 (ibudilast), MN-001 (tipelukast), MN-221 (bedoradrine) and MN-029 (denibulin). MN-166 is an oral, anti-inflammatory and neuroprotective agent. MN-166 is in development for the treatment of several neurological diseases, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, and substance dependence and addiction. MN-001 (tipelukast) is an orally bioavailable small molecule compound, which is used for the treatment of fibrotic diseases, such as nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis. MN-221 treats acute exacerbations of asthma through intravenous infusion, bypassing constricted airways to deliver the drug to the lungs. MN-029 is used for the treatment of solid tumor cancers. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MNOV     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 03   203. 85   241. 91  
42 stocks rank:  4. 36 K 1. 44 K 1. 05 K
# analyst opinions:  2. 00   14. 51   13. 97  
mean recommendation:  1. 50   2. 09   2. 01  

quick ratio:  28. 43   5. 27   1. 81  
current ratio:  28. 63   5. 62   2. 25  

target price low:  18. 00   84. 80   115. 21  
target price avg:  20. 00   111. 51   137. 51  
target price high:  22. 00   135. 81   157. 84  
1-yr high:  12. 83   114. 23   138. 78  
last close:  9. 22   87. 66   116. 69  
50-day avg:  8. 83   95. 54   123. 44  
200-day avg:  9. 61   94. 25   121. 11  
1-yr low:  6. 82   72. 78   98. 34  
volume:  101. 72 K 4. 11 M 8. 07 M
50-day avg volume:  62. 63 K 2. 76 M 5. 02 M
200-day avg volume:  79. 08 K 2. 92 M 4. 59 M

1-day return:  -6. 40 % -0. 41 % 0. 07 %
this week return:  -10. 49 % -5. 74 % -4. 11 %
12-wk return:  -1. 07 % 1. 61 % -0. 05 %
52-wk return:  -11. 10 % 3. 12 % 8. 78 %

enterprise value (EV):  326. 51 M 48. 94 B 114. 64 B
market cap:  388. 82 M 43. 07 B 104. 73 B
EBITDA:  -15. 56 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -20. 98   4. 22   12. 73  
total debt:  0. 00   12. 24 B 16. 73 B
net income (common):  -14. 68 M 2. 20 B 4. 20 B

shares outstanding:  42. 17 M 571. 70 M 1. 24 B
shares:  38. 58 M 571. 81 M 1. 23 B
shares short:  3. 04 M 10. 17 M 13. 00 M
shares short prior month:  3. 10 M 9. 54 M 17. 33 M
short ratio:  63. 68   5. 41   3. 28  
short % of float:  7. 83 % 5. 45 % 2. 38 %
total cash/share:  1. 48   11. 14   9. 33  
total cash:  62. 31 M 6. 71 B 7. 15 B
free cash flow:  -4. 19 M 3. 58 B 2. 96 B
operating cash flow:  -9. 11 M 4. 15 B 4. 30 B

book value:  1. 74   12. 78   26. 92  
price/book:  5. 31   3. 06   -1. 74  
operating margins:  0. 00 % -725. 35 % -89. 04 %
EBITDA margins:  0. 00 % 10. 94 % 22. 51 %
profit margins:  0. 00 % 7. 81 % 10. 57 %
gross margins:  0. 00 % 37. 08 % 55. 70 %

1-yr max volatility:  18. 13 % --- ---
1-yr mean volatility:  0. 01 % 0. 03 % 0. 04 %

1-yr EPS:  -0. 36   2. 40   4. 10  
forward EPS:  -0. 77   3. 97   7. 13  
P/E:  -25. 83   13. 63   22. 72  
forward P/E:  -11. 97   -15. 95   13. 99  
PE/G:  7. 55   -1. 65   -1. 32  
growth:  -3. 42 % 127. 12 % 29. 61 %
earnings high:  -0. 07   1. 00   1. 66  
earnings avg:  -0. 10   0. 77   1. 53  
earnings low:  -0. 14   0. 50   1. 39  
revenue high:  -0. 00   2. 68 B 10. 78 B
revenue avg:  -0. 00   2. 59 B 10. 57 B
revenue low:  -0. 00   2. 49 B 10. 36 B
return on assets:  -16. 15 % -2. 75 % 4. 55 %
return on equity:  -26. 26 % -18. 45 % 5. 46 %

beta (1yr vs S&P500):  1. 58   1. 25   0. 93  
sharpe (1yr):  0. 04   0. 37   0. 70  

held % insiders:  10. 29 % 6. 39 % 3. 38 %
held % institutions:  22. 00 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : MNOV
.    + 2.679 =         2.679 :: INITIAL WEIGHT
.   + 68.174 =        70.853 :: inverse volume-to-price addition
.    + 47.42 =       118.273 :: spline projection addition
.    x 5.528 =       653.775 :: 13 weeks' performance factor
.    x 0.875 =       571.986 :: one-year gains+dividend factor
.    x 1.431 =       818.754 :: industry recommendation factor
.     x 2.42 =      1981.189 :: symbol recommendation factor
.    x 0.998 =       1977.99 :: return on assets factor
.    x 0.997 =      1972.795 :: return on equity factor
.    x 4.804 =      9476.983 :: current ratio factor
.    x 1.018 =      9648.192 :: quick ratio factor
.    x 1.008 =      9723.652 :: short ratio factor
.    x 2.078 =     20206.177 :: price-to-book factor
.    x 1.034 =     20896.528 :: 5-day avg > 200-day avg
.    x 1.126 =     23524.921 :: 5-day avg > 50-day avg
.    x 1.021 =     24013.863 :: P/E weight
.    x 0.603 =      14487.38 :: PE/G factor
.    x 1.451 =     21014.787 :: beta factor
.    x 0.039 =       828.352 :: sharpe factor
.    x 2.089 =      1730.261 :: target low factor
.     x 1.36 =      2353.902 :: target mean factor
.    x 1.118 =      2631.035 :: target high factor
.     x 1.31 =      3446.361 :: industry 2-weeks return factor
.    x 0.931 =      3208.572 :: "drift" penalty 3 days ago
.    x 0.904 =       2899.66 :: "drift" penalty 5 days ago
.    x 0.901 =      2611.418 :: overall "drift" factor
.    x 0.819 =       2137.96 :: largest single-day jump factor
.    x 0.126 =       268.588 :: low price factor
.      x 1.0 =       268.544 :: factor hist industry gain for week 16
.   cubeRoot =         6.452 :: reduced to standardize
.   - 22.357 =         0.027 :: add/subtract for performance
.                      0.027 :: FINAL WEIGHT for NASDAQ:MNOV


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org